281 related articles for article (PubMed ID: 33725579)
1. An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer.
He T; Fong JN; Moore LW; Ezeana CF; Victor D; Divatia M; Vasquez M; Ghobrial RM; Wong STC
Comput Med Imaging Graph; 2021 Apr; 89():101894. PubMed ID: 33725579
[TBL] [Abstract][Full Text] [Related]
2. Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study.
Liu Z; Liu Y; Zhang W; Hong Y; Meng J; Wang J; Zheng S; Xu X
Hepatol Int; 2022 Jun; 16(3):577-589. PubMed ID: 35352293
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
Iseke S; Zeevi T; Kucukkaya AS; Raju R; Gross M; Haider SP; Petukhova-Greenstein A; Kuhn TN; Lin M; Nowak M; Cooper K; Thomas E; Weber MA; Madoff DC; Staib L; Batra R; Chapiro J
AJR Am J Roentgenol; 2023 Feb; 220(2):245-255. PubMed ID: 35975886
[No Abstract] [Full Text] [Related]
4. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
7. Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.
Costentin CE; Amaddeo G; Decaens T; Boudjema K; Bachellier P; Muscari F; Salamé E; Bernard PH; Francoz C; Dharancy S; Vanlemmens C; Radenne S; Dumortier J; Hilleret MN; Chazouillères O; Pageaux GP; Calderaro J; Laurent A; Roudot-Thoraval F; Duvoux C;
Liver Int; 2017 May; 37(5):717-726. PubMed ID: 28199760
[TBL] [Abstract][Full Text] [Related]
8. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.
Mohamed IB; Ismail MS; El Sabagh A; Afifi Abdelwahab AM; Polychronopoulou E; Kuo YF; Hassan M; Goss JA; Kanwal F; Jalal PK
Cancer Med; 2023 Jul; 12(14):15011-15025. PubMed ID: 37326440
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
10. DLNLF-net: Denoised local and non-local deep features fusion network for malignancy characterization of hepatocellular carcinoma.
Huang H; Xie Y; Wang G; Zhang L; Zhou W
Comput Methods Programs Biomed; 2022 Dec; 227():107201. PubMed ID: 36335751
[TBL] [Abstract][Full Text] [Related]
11. Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.
Qu WF; Tian MX; Lu HW; Zhou YF; Liu WR; Tang Z; Yao Z; Huang R; Zhu GQ; Jiang XF; Tao CY; Fang Y; Gao J; Wu XL; Chen JF; Zhao QF; Yang R; Chu TH; Zhou J; Fan J; Yu JH; Shi YH
Hepatol Int; 2023 Aug; 17(4):927-941. PubMed ID: 37031334
[TBL] [Abstract][Full Text] [Related]
12. MRI-Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.
Xia T; Zhao B; Li B; Lei Y; Song Y; Wang Y; Tang T; Ju S
J Magn Reson Imaging; 2024 Mar; 59(3):767-783. PubMed ID: 37647155
[TBL] [Abstract][Full Text] [Related]
13. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.
Song D; Wang Y; Wang W; Wang Y; Cai J; Zhu K; Lv M; Gao Q; Zhou J; Fan J; Rao S; Wang M; Wang X
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3757-3767. PubMed ID: 33839938
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.
Lai Q; Spoletini G; Mennini G; Laureiro ZL; Tsilimigras DI; Pawlik TM; Rossi M
World J Gastroenterol; 2020 Nov; 26(42):6679-6688. PubMed ID: 33268955
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.
Stollmayer R; Budai BK; Tóth A; Kalina I; Hartmann E; Szoldán P; Bérczi V; Maurovich-Horvat P; Kaposi PN
World J Gastroenterol; 2021 Sep; 27(35):5978-5988. PubMed ID: 34629814
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein and
Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
20. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
